PDCD4 and ovarian cancer: In our study, by classifying Pdcd4 expression into two groups using median as a cut-off value, we found that patients with higher Pdcd4 expression had better prognosis in terms of disease-free survival, which implied that Pdcd4 might be a potential prognostic factor to predict the outcomes of ovarian cancer patients.